<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="6801">Metformin</z:chebi> is a cornerstone in the treatment of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Although its mechanism of action is not well understood, there is new evidence about its possible role in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>A Pubmed search from 1990 to 2011 was done using the terms <z:chebi fb="0" ids="6801">metformin</z:chebi>, <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, mechanism of action, <z:mp ids='MP_0002055'>diabetes</z:mp> treatment and prevention </plain></SENT>
<SENT sid="3" pm="."><plain>We found more than one thousand articles and reviewed studies that had assessed the efficacy of <z:chebi fb="0" ids="6801">metformin</z:chebi> in treatment and prevention of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and its mechanisms of actions, as well as articles on its antitumoral effects </plain></SENT>
<SENT sid="4" pm="."><plain>We found that the United Kingdom Prospective <z:mp ids='MP_0002055'>Diabetes</z:mp> Study and the <z:mp ids='MP_0002055'>Diabetes</z:mp> Prevention Program have demonstrated the efficacy of <z:chebi fb="0" ids="6801">metformin</z:chebi> in terms of treatment and prevention of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>; <z:chebi fb="0" ids="6801">metformin</z:chebi> is safe, cost effective and remains the first line of <z:mp ids='MP_0002055'>diabetes</z:mp> therapy with diet and exercise </plain></SENT>
<SENT sid="5" pm="."><plain>The mechanisms of action include a decrease of hepatic <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, change in <z:chebi fb="1" ids="3098">bile acids</z:chebi> metabolism, incretins release and decreased amyloid deposits </plain></SENT>
<SENT sid="6" pm="."><plain>The <z:chebi fb="47" ids="16027,28971">AMP</z:chebi>-activated protein kinase seems to be an important target for these effects </plain></SENT>
<SENT sid="7" pm="."><plain>Epidemiological retrospective studies point out a possible association between <z:chebi fb="0" ids="6801">metformin</z:chebi> and decreased <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk, data supported by in vitro and animal studies </plain></SENT>
<SENT sid="8" pm="."><plain>These data should trigger randomized controlled trials to prove or disprove this additional benefit of <z:chebi fb="0" ids="6801">metformin</z:chebi> </plain></SENT>
</text></document>